mla is in stealth mode, page-5

The concord hospital announcement IMO will prove to be very significant.

Firstly, the reason they are switching to the product is for efficiency and cost savings and it appears to be superior to the current product. Secondly, this is a major teaching hospital so every year graduate doctors and nurses who go out to new hospitals will ask why their new hospitals don't use a cheaper and better alternative.

As such uptake in other hospitals should prove quite rapid to say nothing of the ambulances as well.

As to share price the impending option expiry IMO will prove to be the reason the stock has not moved up with this and the UK medivet deal.

Anyone deciding not to invest more money into MLA that received the options as part of the 1.5cts rights issue will be either selling out their options or selling the ord shares to finance the option exercise.

Don't be surprised if the selling pressure reduces over the next week.

Regardless given the announcements to date sales and cashflow growth over FY 2012 and 2013 would appear fairly certain.